Prostaglandin D2 pathway upregulation: Relation to asthma severity, control, and TH2 inflammation

Journal of Allergy and Clinical Immunology

Volumn 131, Issue 6, 2013, Pages

  Fajt, Merritt L ^a   Gelhaus, Stacy L ^a   Freeman, Bruce ^a   Uvalle, Crystal E ^a   Trudeau, John B ^a   Holguin, Fernando ^a   Wenzel, Sally E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma control; severe asthma

Indexed keywords

CHEMOATTRACTANT RECEPTOR HOMOLOGOUS MOLECULE EXPRESSED ON TH2; CYTOKINE; MAST CELL PROTEINASE; NITRIC OXIDE; PROSTAGLANDIN D2; PROTEINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; BRONCHOSCOPY; CLINICAL ARTICLE; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84878592151     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.01.035     Document Type: Article

References (39)

1. American Thoracic Society Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions Am J Respir Crit Care Med 162 2000 2341 2351
2. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: expert panel report 3 (EPR3). Bethesda (MD): National Institutes of Health/National Heart, Lung, and Blood Institute; 2007. Publication no. 08-4051. Available at: http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.pdf. Accessed January 16, 2012.
3. W.C. Moore, E.R. Bleecker, D. Curran-Everett, S.C. Erzurum, B.T. Ameredes, and L. Bacharier National Heart, Lung, Blood Institute's Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program J Allergy Clin Immunol 119 2007 405 413
4. S. Balzar, H.W. Chu, M. Strand, and S. Wenzel Relationship of small airway chymase-positive mast cells and lung function in severe asthma Am J Respir Crit Care Med 171 2005 431 439
5. S.E. Wenzel, S. Balzar, E. Ampleford, G.A. Hawkins, W.W. Busse, and W.J. Calhoun IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression Am J Respir Crit Care Med 175 2007 570 576
6. S. Balzar, M.L. Fajt, S.A. Comhair, S.C. Erzurum, E. Bleecker, and W.W. Busse Mast cell phenotype, location, and activation in severe asthma: data from the severe asthma research program Am J Respir Crit Care Med 183 2011 299 309
7. S.J. Galli, S. Nakae, and M. Tsai Mast cells in the development of adaptive immune responses Nat Immunol 6 2005 135 142
8. Y. Kanaoka, K. Fujimori, R. Kikuno, Y. Sakaguchi, Y. Urade, and O. Hayaishi Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase. Conservation of the ancestral genomic structure of sigma-class glutathione S-transferase Eur J Biochem 267 2000 3315 3322
9. J.L. Herlong, and T.R. Scott Positioning prostanoids of the D and J series in the immunopathogenic scheme Immunol Lett 102 2006 121 131
10. R. Pettipher, T.T. Hansel, and R. Armer Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases Nat Rev Drug Discov 6 2007 313 325
11. F. Nantel, C. Fong, S. Lamontagne, D.H. Wright, A. Giaid, and M. Desrosiers Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa Prostaglandins Other Lipid Mediat 73 2004 87 101
12. M. Okano, T. Fujiwara, Y. Sugata, D. Gotoh, Y. Masaoka, and M. Sogo Presence and characterization of prostaglandin D2-related molecules in nasal mucosa of patients with allergic rhinitis Am J Rhinol 20 2006 342 348
13. J.P. Abonia, C. Blanchard, B.B. Butz, H.F. Rainey, M.H. Collins, and K. Stringer Involvement of mast cells in eosinophilic esophagitis J Allergy Clin Immunol 126 2010 140 149
14. K. Tanaka, H. Hirai, S. Takano, M. Nakamura, and K. Nagata Effects of prostaglandin D2 on helper T cell functions Biochem Biophys Res Commun 316 2004 1009 1014
15. P. Gosset, M. Pichavant, C. Faveeuw, F. Bureau, A.B. Tonnel, and F. Trottein Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response Eur J Immunol 35 2005 1491 1500
16. K.J. Stebbins, A.R. Broadhead, L.D. Correa, J.M. Scott, Y.P. Truong, and B.A. Stearns Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation Eur J Pharmacol 638 2010 142 149
17. N. Barnes, I. Pavord, A. Chuchalin, J. Bell, M. Hunter, and T. Lewis A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma Clin Exp Allergy 42 2012 38 48
18. D. Singh, P. Cadden, M. Hunter, L.P. Collins, M. Perkins, and R. Pettipher Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 Eur Respir J 41 2012 46 52
19. M.L. Fajt, S. Balzar, J.B. Trudeau, J.Y. Westcott, and S.E. Wenzel Elevated prostaglandin D2 (PGD2) levels in bronchoalveolar lavage fluid (BALF) in severe asthma J Allergy Clin Immunol 125 2010 AB43
20. M.L. Fajt, S. Balzar, J.B. Trudeau, H. Hu, and S.E. Wenzel Epithelial hematopoietic prostaglandin (PG) D synthase is increased in asthma Am J Respir Crit Care Med 181 2010 A1440
21. M.L. Fajt, S. Balzar, J.B. Trudeau, and S.E. Wenzel CRTH2 receptor and its ligand, PGD2, are increased in severe asthma Am J Respir Crit Care Med 183 2011 A4446
22. E.F. Juniper, G.H. Guyatt, R.S. Epstein, P.J. Ferrie, R. Jaeschke, and T.K. Hiller Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials Thorax 47 1992 76 83
23. W.C. Moore, M.D. Evans, E.R. Bleecker, W.W. Busse, W.J. Calhoun, and M. Castro National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Safety of investigative bronchoscopy in the Severe Asthma Research Program J Allergy Clin Immunol 128 2011 328 336.e3
24. K. Chibana, J.B. Trudeau, A.T. Mustovich, H. Hu, J. Zhao, and S. Balzar IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells Clin Exp Allergy 38 2008 936 946
25. J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, and J.R. Arron Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
26. I.D. Pavord, S. Korn, P. Howarth, E.R. Bleecker, R. Buhl, and O.N. Keene Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial Lancet 380 2012 651 659
27. I. Mahmud, N. Ueda, H. Yamaguchi, R. Yamashita, S. Yamamoto, and Y. Kanaoka Prostaglandin D synthase in human megakaryoblastic cells J Biol Chem 272 1997 28263 28266
28. K. Fujimori, Y. Kanaoka, Y. Sakaguchi, and Y. Urade Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. Roles of the oct-1 element in the 5'-flanking region and the AP-2 element in the untranslated exon 1 J Biol Chem 275 2000 40511 40516
29. T. Luna-Gomes, K.G. Magalhães, F.P. Mesquita-Santos, I. Bakker-Abreu, R.F. Samico, and R. Molinaro Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation J Immunol 187 2011 6518 6526
30. G. Philip, J. van Adelsberg, T. Loeys, N. Liu, P. Wong, and E. Lai Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis J Allergy Clin Immunol 124 2009 942 948
31. L. Xue, S.L. Gyles, F.R. Wettey, L. Gazi, E. Townsend, and M.G. Hunter Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells J Immunol 175 2005 6531 6536
32. R. Pettipher, S.L. Vinall, L. Xue, G. Speight, E.R. Townsend, and L. Gazi Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils J Pharmacol Exp Ther 340 2012 473 482
33. W.W. Busse, S.E. Wenzel, E.O. Meltzer, E.M. Kerwin, M.C. Liu, and N. Zhang Safety and efficacy of the prostaglandin D(2) receptor antagonist AMG 853 in asthmatic patients J Allergy Clin Immunol 131 2013 339 345
34. R.H. Dougherty, S.S. Sidhu, K. Raman, M. Solon, O.D. Solberg, and G.H. Caughey Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma J Allergy Clin Immunol 125 2010 1046 1053
35. W.C. Moore, E.R. Bleecker, D. Curran-Everett, S.C. Erzurum, B.T. Ameredes, and L. Bacharier National Heart, Lung, Blood Institute's Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program J Allergy Clin Immunol 119 2007 405 413
36. S. Balzar, M.L. Fajt, S.A. Comhair, S.C. Erzurum, E. Bleecker, and W.W. Busse Mast cell phenotype, location, and activation in severe asthma: data from the severe asthma research program Am J Respir Crit Care Med 183 2011 299 309
37. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: expert panel report 3 (EPR3). Bethesda (MD): National Institutes of Health/National Heart, Lung, and Blood Institute; 2007. Publication no. 08-4051. Available at: http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.pdf. Accessed January 16, 2012.
38. E.F. Juniper, G.H. Guyatt, R.S. Epstein, P.J. Ferrie, R. Jaeschke, and T.K. Hiller Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials Thorax 47 1992 76 83
39. W.C. Moore, M.D. Evans, E.R. Bleecker, W.W. Busse, W.J. Calhoun, and M. Castro National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Safety of investigative bronchoscopy in the Severe Asthma Research Program J Allergy Clin Immunol 128 2011 328 336.e3